Dashboard
Manage Tickers

KZIA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

kazia-therapeutics-enters-exclusive-collaboration-and-in-licensing-agreement-with-qimr-berghofer-for-first-in-class-pd-l1-degrader-program
Kazia Therapeutics Enters Exclusive Collab...
10/07/2025 12:42:56

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today announced an exclusive collaborat...

maxim-group-maintains-buy-on-kazia-therapeutics-raises-price-target-to-20
Maxim Group Maintains Buy on Kazia Therape...
10/02/2025 15:15:45

Maxim Group analyst Naz Rahman maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target from $15 to...

kazia-therapeutics-reports-reduction-in-tumor-burden-from-a-single-patient-expanded-access-case-in-triple-negative-breast-cancer-treated-with-a-combination-regimen-that-included-the-cos-investigational-pan-pi3kmtor-inhibitor-paxalisib-after-3-weeks-of-combination-immunotherapychemotherapy-plus-paxalisib-imaging-performed-at-the-treating-institution-showed-an-86-reduction-in-overall-tumor-burden
Kazia Therapeutics Reports Reduction In Tu...
10/02/2025 12:36:24

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today reported a substantial reduction ...

kazia-therapeutics-announces-its-participation-in-a-fully-funded-australian-medical-research-future-fund-project-titled-sequential--temporal-therapeutic-agility-for-the-treatment-of-diffuse-midline-glioma
Kazia Therapeutics Announces Its Participa...
10/01/2025 13:23:16

Kazia Therapeutics Limited (NASDAQ:KZIA), a clinical-stage biotechnology company developing innovative therapies for brain canc...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 12:10:10

kazia-therapeutics-paxalisib-shows-complete-disruption-of-metastatic-cell-clusters-in-stage-iv-her2-positive-breast-cancer-study
Kazia Therapeutics' Paxalisib Shows Comple...
09/11/2025 12:05:33

Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company, today announced new findings from a col...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

kazia-therapeutics-announces-2m-private-placement-securities-priced-at-5-premium-to-jul-31-ads-closing-pricec
Kazia Therapeutics Announces $2M Private P...
08/01/2025 12:07:56

hc-wainwright--co-maintains-buy-on-kazia-therapeutics-raises-price-target-to-13
HC Wainwright & Co. Maintains Buy on Kazia...
07/10/2025 10:35:48

HC Wainwright & Co. analyst Sean Lee maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and raises the price target f...

kazia-reports-over-50-cancer-cell-reduction-in-early-data-from-breast-cancer-trial-stock-jumps
Kazia Reports Over 50% Cancer Cell Reducti...
07/09/2025 18:47:12

Kazia's early trial data show significant CTC and cluster reduction in a breast cancer patient treated with Paxalisib, Keyt...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 17:06:52

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 12:07:32

kazia-therapeutics-announces-preliminary-results-from-first-patient-in-phase-1b-trial-evaluating-combination-regimen-of-paxalisib-pembrolizumab-and-standard-chemotherapy-after-completing-cycle-1-of-dosing
Kazia Therapeutics Announces Preliminary R...
07/09/2025 12:03:01

Kazia Therapeutics (NASDAQ:KZIA) is pleased to announce preliminary results from the first patient in its Phase 1b trial evalua...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/08/2025 12:07:32

maxim-group-maintains-buy-on-kazia-therapeutics-maintains-15-price-target
Maxim Group Maintains Buy on Kazia Therape...
06/11/2025 17:32:36

Maxim Group analyst Jason McCarthy maintains Kazia Therapeutics (NASDAQ:KZIA) with a Buy and maintains $15 price target.

kazia-therapeutics-kzia-stock-surges-77-on-positive-preclinical-data-for-breast-cancer-drug
Kazia Therapeutics (KZIA) Stock Surges 77%...
06/11/2025 17:07:09

Kazia on Wednesday announced positive preclinical data for its paxalisib drug in triple-negative breast cancer. The company'...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/11/2025 17:06:34

kazia-therapeutics-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-981
Kazia Therapeutics Shares Halted On Circui...
06/11/2025 14:53:08

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/11/2025 12:07:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION